Alter Pharma acquires EcoPharmaSupply | Your money

ANDERLECHT, Belgium–(BUSINESS WIRE)–April 6, 2022–

PES is a Belgian pharmaceutical services and products company, distributor and partner of choice for several pharmaceutical brands in the Benelux market, including prescription drugs, medical devices, over-the-counter pharmaceuticals and consumer healthcare products. The investment will enable Alter Pharma to enhance its services and product offering by further leveraging its regulatory compliance and market know-how while leveraging its extensive supply and logistics network.

This press release is multimedia. See the full version here: https://www.businesswire.com/news/home/20220406006079/en/

“Our strength lies in our agility to respond to market needs in very short timeframes and this is of crucial importance in the pharmacy services and distribution markets”, commented Grégory Tjoens, CEO of EPS. “We are confident that by combining the services and products of both companies, we will be a key partner for hospital and retail pharmacies in the Benelux and beyond.”

“The acquisition of EPS fits perfectly with our mission to make affordable medicines available to everyone,” continued Filip Van de Vliet, CEO of EPS. Alter Pharma Group, “because it gives us instant access to a strategic platform allowing us to be, even more than today, the unique partner of the Benelux hospital and distribution pharmacist. This adds to our already strong pharmacy house and further expands our toolbox to support pharmacists in their quest to help patients with continued access to affordable, high quality medications.

The Alter Pharma group realizes its mission not only in Europe, but also on the American market (through Milla Pharmaceuticals Inc..), where it recently launched several of its own developed injectables, including those on the US Drug Shortage List, bringing relief to patients in need.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220406006079/en/

CONTACT: Alter Pharma Group NV/SA

www.alterpharmagroup.beFilip Van de Vliet1

Chairman and Chief Executive Officer / Chief Executive Officer

Alter Pharma Group SA

+32 477 86 24 72

[email protected] Voets2

Legal, ESG & Communication Director

Alter Pharma Group SA

+32 498 48 77 68

[email protected] permanent representative of Themtis BV

2As a permanent representative of EV Productions BV

KEYWORD: BELGIUM EUROPE

INDUSTRY KEYWORD: PHARMACEUTICAL OTHER MANUFACTURING GENERAL HEALTH HEALTH MEDICAL DEVICES SUPPLY CHAIN ​​MANAGEMENT MANUFACTURING RETAIL

SOURCE: Alter Pharma Group

Copyright BusinessWire 2022.

PUBLISHED: 04/06/2022 11:08 PM / DISK: 04/06/2022 11:08 PM

http://www.businesswire.com/news/home/20220406006079/en

Copyright BusinessWire 2022.